CHEMFirm is a revolutionary drug analysis platform based on CHEMSAS® that is positioned to rapidly and meaningfully improve the drug discovery process and improve biopharmaceutical investment performance.
The system is used to identify small molecules with a pharmacological profile that increases the likelihood of success during drug development. A series of computer simulations is used to model many important properties of the molecule. The CHEMFirm process helps medicinal chemists to be more efficient and investors make more informed decisions.
For more information on CHEMFirm, please contact Dr. Wayne Danter.
